Semaglutide and Trizepatide are the active ingredient in the leading brands in weight-loss such as Zepbound,Monjaro ,Ozempic, Wegovy, and Rybelsus. GLP-1 is used for weight loss in specific patients, and also to lower blood sugar levels, and to reduce the risk of major cardiovascular events such as heart attack or stroke in certain patients. Semaglutide and Trizepatide GLP-1 agonist work by increasing insulin release, lowering the amount of glucagon released, delaying gastric emptying, and reducing appetite